• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合成磷酸肽免疫原可产生针对c-erbB-2受体的激活特异性抗体。

Synthetic phosphopeptide immunogens yield activation-specific antibodies to the c-erbB-2 receptor.

作者信息

Epstein R J, Druker B J, Roberts T M, Stiles C D

机构信息

Division of Cell and Molecular Biology, Dana-Farber Cancer Institute, Boston, MA.

出版信息

Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10435-9. doi: 10.1073/pnas.89.21.10435.

DOI:10.1073/pnas.89.21.10435
PMID:1359539
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC50353/
Abstract

We inoculated rabbits with synthetic phosphopeptides, duplicating a major autophosphorylation site of the c-erbB-2 protooncogene product. The rabbits produced antisera that, after reverse immunoaffinity purification, selectively recognize the erbB-2 protein in its enzymatically active configuration. These anti-phosphopeptide antisera identify a subset of erbB-2-positive human cell lines wherein the protein is constitutively active as a tyrosine kinase. Synthetic phosphopeptides incorporating informative protein phosphorylation sites may prove useful for generating antibodies that indicate the activation state of additional tyrosine kinases and perhaps other proteins phosphorylated on serine and threonine residues.

摘要

我们用合成磷酸肽对兔子进行接种,复制c-erbB-2原癌基因产物的一个主要自磷酸化位点。兔子产生了抗血清,经过反向免疫亲和纯化后,能选择性识别处于酶活性构型的erbB-2蛋白。这些抗磷酸肽抗血清识别出一部分erbB-2阳性人类细胞系,其中该蛋白作为酪氨酸激酶持续处于激活状态。包含信息丰富的蛋白质磷酸化位点的合成磷酸肽可能被证明有助于生成指示其他酪氨酸激酶以及可能其他在丝氨酸和苏氨酸残基上磷酸化的蛋白质激活状态的抗体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c8/50353/0a89b7844bc9/pnas01095-0473-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c8/50353/50d1a64d3f0d/pnas01095-0471-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c8/50353/672726421c34/pnas01095-0472-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c8/50353/1528c326eec3/pnas01095-0473-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c8/50353/a5417f84c6d6/pnas01095-0473-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c8/50353/0a89b7844bc9/pnas01095-0473-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c8/50353/50d1a64d3f0d/pnas01095-0471-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c8/50353/672726421c34/pnas01095-0472-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c8/50353/1528c326eec3/pnas01095-0473-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c8/50353/a5417f84c6d6/pnas01095-0473-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c8/50353/0a89b7844bc9/pnas01095-0473-c.jpg

相似文献

1
Synthetic phosphopeptide immunogens yield activation-specific antibodies to the c-erbB-2 receptor.合成磷酸肽免疫原可产生针对c-erbB-2受体的激活特异性抗体。
Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10435-9. doi: 10.1073/pnas.89.21.10435.
2
Preferential detection of catalytically inactive c-erbB-2 by antibodies to unphosphorylated peptides mimicking receptor tyrosine autophosphorylation sites.
Oncogene. 1995 Jul 20;11(2):315-23.
3
Agonistic antibodies stimulate the kinase encoded by the neu protooncogene in living cells but the oncogenic mutant is constitutively active.激动性抗体可刺激活细胞中neu原癌基因编码的激酶,但致癌突变体具有组成性活性。
Proc Natl Acad Sci U S A. 1990 Apr;87(7):2569-73. doi: 10.1073/pnas.87.7.2569.
4
Signal transduction by the neu/erbB-2 receptor: a potential target for anti-tumor therapy.神经/表皮生长因子受体2(neu/erbB-2)介导的信号转导:抗肿瘤治疗的一个潜在靶点
J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):95-103. doi: 10.1016/0960-0760(92)90192-l.
5
The transforming potential of the c-erbB-2 protein is regulated by its autophosphorylation at the carboxyl-terminal domain.c-erbB-2蛋白的转化潜能受其羧基末端结构域自磷酸化的调控。
Mol Cell Biol. 1991 Feb;11(2):833-42. doi: 10.1128/mcb.11.2.833-842.1991.
6
TPA inhibits the tyrosine kinase activity of the neu protein in vivo and in vitro.组织型纤溶酶原激活剂在体内和体外均能抑制neu蛋白的酪氨酸激酶活性。
Oncogene. 1991 May;6(5):705-11.
7
Biological effects of monoclonal antireceptor antibodies reactive with neu oncogene product, p185neu.
Methods Enzymol. 1991;198:277-90. doi: 10.1016/0076-6879(91)98029-6.
8
Preparation and application of antibodies to phosphoamino acid sequences.磷酸化氨基酸序列抗体的制备与应用。
Biopolymers. 2001;60(1):61-75. doi: 10.1002/1097-0282(2001)60:1<61::AID-BIP1004>3.0.CO;2-4.
9
Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors.通过替代受体激活布鲁顿酪氨酸激酶过程中两个调节性酪氨酸残基的磷酸化
Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11526-33. doi: 10.1073/pnas.94.21.11526.
10
The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand.正常的erbB-2产物是一种非典型的受体样酪氨酸激酶,在没有配体的情况下具有组成性活性。
New Biol. 1990 Nov;2(11):992-1003.

引用本文的文献

1
The antibody sc-33040-R fails to specifically recognize phosphorylation of ErbB4 on tyrosine1056.抗体sc-33040-R无法特异性识别ErbB4在酪氨酸1056位点的磷酸化。
Growth Factors. 2007 Oct;25(5):329-33. doi: 10.1080/08977190701804008.
2
Phosphorylation state-specific antibodies: applications in investigative and diagnostic pathology.磷酸化状态特异性抗体:在研究性和诊断性病理学中的应用。
Am J Pathol. 2003 Nov;163(5):1687-98. doi: 10.1016/S0002-9440(10)63525-0.
3
Dominant negative knockout of p53 abolishes ErbB2-dependent apoptosis and permits growth acceleration in human breast cancer cells.

本文引用的文献

1
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.人类乳腺癌:HER-2/neu癌基因扩增与复发及生存的相关性。
Science. 1987 Jan 9;235(4785):177-82. doi: 10.1126/science.3798106.
2
Expression of the c-erbB-2 protein in normal and transformed cells.c-erbB-2蛋白在正常细胞和转化细胞中的表达。
Int J Cancer. 1987 Aug 15;40(2):246-54. doi: 10.1002/ijc.2910400221.
3
The protein kinase family: conserved features and deduced phylogeny of the catalytic domains.蛋白激酶家族:催化结构域的保守特征与推导的系统发育
p53的显性负向敲除消除了人乳腺癌细胞中ErbB2依赖性凋亡并允许生长加速。
Br J Cancer. 2002 Apr 8;86(7):1104-9. doi: 10.1038/sj.bjc.6600219.
4
Association of ErbB2 Ser1113 phosphorylation with epidermal growth factor receptor co-expression and poor prognosis in human breast cancer.人乳腺癌中ErbB2第1113位丝氨酸磷酸化与表皮生长因子受体共表达及预后不良的相关性
Mol Cell Biochem. 2001 Feb;218(1-2):47-54. doi: 10.1023/a:1007249004222.
5
Extracting functional information from tissues.
Mol Diagn. 2001 Mar;6(1):13-5. doi: 10.1007/BF03262099.
6
Phosphorylation of tyrosine 992, 1068, and 1086 is required for conformational change of the human epidermal growth factor receptor c-terminal tail.人表皮生长因子受体C末端尾巴的构象变化需要酪氨酸992、1068和1086的磷酸化。
Mol Biol Cell. 1999 Mar;10(3):525-36. doi: 10.1091/mbc.10.3.525.
7
Proxy activation of protein ErbB2 by heterologous ligands implies a heterotetrameric mode of receptor tyrosine kinase interaction.通过异源配体对蛋白质ErbB2进行的替代激活意味着受体酪氨酸激酶相互作用的异源四聚体模式。
Biochem J. 1998 Apr 1;331 ( Pt 1)(Pt 1):113-9. doi: 10.1042/bj3310113.
8
Activation of ErbB2 during wallerian degeneration of sciatic nerve.坐骨神经华勒氏变性过程中ErbB2的激活。
J Neurosci. 1997 Nov 1;17(21):8293-9. doi: 10.1523/JNEUROSCI.17-21-08293.1997.
9
Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors.通过替代受体激活布鲁顿酪氨酸激酶过程中两个调节性酪氨酸残基的磷酸化
Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11526-33. doi: 10.1073/pnas.94.21.11526.
10
Type 1 receptor tyrosine kinases are differentially phosphorylated in mammary carcinoma and differentially associated with steroid receptors.1型受体酪氨酸激酶在乳腺癌中存在差异磷酸化,且与类固醇受体存在差异关联。
Am J Pathol. 1996 Feb;148(2):549-58.
Science. 1988 Jul 1;241(4861):42-52. doi: 10.1126/science.3291115.
4
EGF-stimulated tyrosine phosphorylation of p185neu: a potential model for receptor interactions.表皮生长因子刺激的p185neu酪氨酸磷酸化:一种受体相互作用的潜在模型。
EMBO J. 1988 Apr;7(4):995-1001. doi: 10.1002/j.1460-2075.1988.tb02906.x.
5
Immunohistochemical distribution of c-erbB-2 in infiltrating and in situ breast cancer.c-erbB-2在浸润性和原位乳腺癌中的免疫组织化学分布
Int J Cancer. 1988 Dec 15;42(6):842-5. doi: 10.1002/ijc.2910420608.
6
Egf binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3.表皮生长因子(EGF)与其受体结合会引发乳腺肿瘤细胞系SK - BR - 3中erbB - 2蛋白的快速酪氨酸磷酸化。
EMBO J. 1988 Jun;7(6):1647-51. doi: 10.1002/j.1460-2075.1988.tb02991.x.
7
Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading.
Cancer Res. 1988 Mar 1;48(5):1238-43.
8
Ligand activation causes a phosphorylation-dependent change in platelet-derived growth factor receptor conformation.配体激活导致血小板衍生生长因子受体构象发生磷酸化依赖性变化。
J Biol Chem. 1988 Sep 15;263(26):12805-8.
9
A point mutation in the neu oncogene mimics ligand induction of receptor aggregation.neu原癌基因中的一个点突变模拟了配体诱导的受体聚集。
Nature. 1989 May 18;339(6221):230-1. doi: 10.1038/339230a0.
10
HER2/neu amplification and comedo type breast carcinoma.人表皮生长因子受体2/神经(HER2/neu)基因扩增与粉刺型乳腺癌
Lancet. 1989 Jun 3;1(8649):1268-9. doi: 10.1016/s0140-6736(89)92365-9.